News | Artificial Intelligence | October 02, 2017

Strategic Radiology to Contribute to IBM Watson's Education

Nationwide radiology network will help artificial intelligence more quickly recognize medical imaging terms that would be found in a patient’s EMR

Strategic Radiology to Contribute to IBM Watson's Education

October 2, 2017 — Thirty radiologists from seven of Strategic Radiology’s 26 member practices will contribute to work undertaken by the Watson Health Medical Imaging Collaborative to advance natural language processing capabilities used in future cognitive medical imaging solutions. The radiologists will provide expert annotation of de-identified medical images that will be used by IBM to train Watson to recognize various medical imaging terms that would be found in a patient’s electronic medical record (EMR), as well as providing feedback on solution design.

“Machine learning is here, and we want to be central to understanding how this important new tool can be leveraged to improve quality and value in radiology,” said A. Van Moore Jr, M.D., FACR, chair and CEO of Strategic Radiology. “We look forward to working with IBM to develop a role for artificial intelligence in medical imaging.”

Just as search engines categorize information in order to index and rank content, Watson is being trained by radiologists to review patient records that include a radiology report and categorize the relevant text from those records into groupings. For example, if Watson can be taught to recognize relevant clinical information in free text notes, a time-consuming task could be performed by Watson and provided in advance to the interpreting radiologist.

Strategic Radiology is a member of Watson Health’s medical imaging collaborative, a global initiative comprised of leading health systems, academic medical centers, private radiology practices, ambulatory radiology providers and imaging technology companies that are finding ways to use medical imaging to identify and predict the risk of cancer, diabetes, and diseases of the eye, brain and heart and related conditions.

Watson is a cloud-based system that analyzes high volumes of data, understands complex questions in basic language and proposes evidence-based answers. Watson can continuously learn, gaining knowledge over time from previous interactions.

For more information:

Related Content

Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
Johns Hopkins Named Qualified Provider-led Entity to Develop Criteria for Diagnostic Imaging
News | Clinical Decision Support | July 18, 2019
On June 30, 2019, the Centers for Medicare & Medicaid Services (CMS) announced the Johns Hopkins University School...
Anatomage Releases Anatomage Cloud Platform
News | Remote Viewing Systems | July 16, 2019
Anatomage Inc. released an update to the Anatomage Cloud platform that allows medical and dental professionals to...
Graphic courtesy Pixabay

Graphic courtesy Pixabay

Feature | Artificial Intelligence | July 15, 2019 | By Greg Freiherr
Siemens has long focused on automation as a way to make diagnostic equipment faster and more efficient.
Videos | Artificial Intelligence | July 12, 2019
Khan Siddiqui, M.D., founder and CEO of HOPPR, discusses the economic advantages and costs presented by...
Videos | Digital Pathology | July 11, 2019
Toby Cornish, M.D., Ph.D., associate professor and medical director of informatics at the University of Colorado Scho
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Researchers Use Artificial Intelligence to Deliver Personalized Radiation Therapy
News | Radiation Therapy | July 09, 2019
New Cleveland Clinic-led research shows that artificial intelligence (AI) can use medical scans and health records to...